Cytochrome P450 epoxygenase CYP2J2 and the risk of coronary artery disease

被引：44
|
作者：
Spiecker, Martin
Liao, James K.
机构：
[1] Brigham & Womens Hosp, Cambridge, MA 02139 USA
[2] St Josef Hosp Bochum, Dept Med 2, D-44791 Bochum, Germany
来源：
TRENDS IN CARDIOVASCULAR MEDICINE | 2006年 / 16卷 / 06期
关键词：
D O I：
10.1016/j.tcm.2006.04.001
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Cytochrome P450 (CYP) enzyme 2J2, an epoxygenase predominantly expressed in the heart, metabolizes arachidonic acid to biologically active eicosanoids. One of the CYP2J2 products, 11,12-epoxyeicosatrienoic acid, has several vasoprotective effects. A frequent promoter polymorphism of CYP2J2 decreases gene expression and is associated with coronary artery disease. This association supports the vascular protective role of CYP-derived eicosanoids in cardiovascular disease.
引用
收藏
页码：204 / 208
页数：5
相关论文
共 50 条
  • [31] Genetic Variation in the G-50T Polymorphism of the Cytochrome P450 Epoxygenase CYP2J2 Gene and the Risk of Younger Onset Type 2 Diabetes among Chinese Population: Potential Interaction with Body Mass Index and Family History
    Wang, C. -P.
    Hung, W. -C.
    Yu, T. -H.
    Chiu, C. -A.
    Lu, L. -F.
    Chung, F. -M.
    Hung, C. -H.
    Shin, S. -J.
    Chen, H. -J.
    Lee, Y. -J.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2010, 118 (06) : 346 - 352
  • [32] A novel polymorphism of the CYP2J2 gene is associated with coronary artery disease in Uygur population in China
    Zhu, Qing
    Fu, Zhenyan
    Ma, Yitong
    Yang, Hong
    Huang, Ding
    Xie, Xiang
    Liu, Fen
    Zheng, Yingying
    Cha, Erdenbat
    CLINICAL BIOCHEMISTRY, 2013, 46 (12) : 1047 - 1054
  • [33] CYTOCHROME P450 (CYP2E1) AS A RISK FACTOR FOR ALCOHOLIC LIVER DISEASE (ALD)
    Seitz, H. K.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2018, 42 : 62A - 62A
  • [34] Genetic variation in CYP2J2 and risk of coronary heart disease: The atherosclerosis risk in communities (ARIC) study
    Lee, Craig R.
    North, Kari E.
    Bray, Molly S.
    Couper, David J.
    Heiss, Gerardo
    Zeldin, Darryl C.
    CIRCULATION, 2006, 114 (18) : 490 - 490
  • [35] Cytochrome P450 (CYP) in fish
    Uno, Tomohide
    Ishizuka, Mayumi
    Itakura, Takao
    ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2012, 34 (01) : 1 - 13
  • [36] Let-7b Inhibits Human Cancer Phenotype by Targeting Cytochrome P450 Epoxygenase 2J2
    Chen, Fuqiong
    Chen, Chen
    Yang, Shenglan
    Gong, Wei
    Wang, Yan
    Cianflone, Katherine
    Tang, Jiarong
    Wang, Dao Wen
    PLOS ONE, 2012, 7 (06):
  • [37] Polymorphisms of cytochrome P450 1A1, cigarette smoking and risk of coronary artery disease
    Yeh, Chih-Ching
    Sung, Fung-Chang
    Kuo, Li-Tang
    Hsu, Wan-Ping
    Chu, Hsiang-Yu
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2009, 667 (1-2) : 77 - 81
  • [38] Asymmetric Binding and Metabolism of Polyunsaturated Fatty Acids (PUFAs) by CYP2J2 Epoxygenase
    Arnold, William R.
    Baylon, Javier L.
    Tajkhorshid, Emad
    Das, Aditi
    BIOCHEMISTRY, 2016, 55 (50) : 6969 - 6980
  • [39] Regulation of the cerebral circulation by cytochrome P450 epoxygenase activity
    Peng, XQ
    Carhuapoma, JR
    Bhardwaj, A
    Alkayed, NJ
    Harder, DR
    Traystman, RJ
    Koehler, RC
    BRAIN ACTIVATION AND CBF CONTROL, PROCEEDINGS, 2002, 1235 : 289 - 295
  • [40] CYP2J2 and CYP2C8 polymorphisms and coronary heart disease risk:: the Atherosclerosis Risk in Communities (ARIC) study
    Lee, Craig R.
    North, Kari E.
    Bray, Molly S.
    Couper, David J.
    Heiss, Gerardo
    Zeldin, Darryl C.
    PHARMACOGENETICS AND GENOMICS, 2007, 17 (05): : 349 - 358
12345